Adocia (Adocia) Beginning Cash Position : $13.22 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Adocia Beginning Cash Position?

Adocia's Beginning Cash Position for the quarter that ended in Dec. 2023 was $13.22 Mil.

Adocia's quarterly Beginning Cash Position declined from Dec. 2022 ($25.35 Mil) to Jun. 2023 ($18.88 Mil) and declined from Jun. 2023 ($18.88 Mil) to Dec. 2023 ($13.22 Mil).

Adocia's annual Beginning Cash Position declined from Dec. 2021 ($31.77 Mil) to Dec. 2022 ($16.07 Mil) but then increased from Dec. 2022 ($16.07 Mil) to Dec. 2023 ($19.00 Mil).

Adocia Beginning Cash Position Historical Data

The historical data trend for Adocia's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adocia Beginning Cash Position Chart

Adocia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

44.27

53.11

31.77

16.07

19.00

Adocia Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															23.35	16.03	25.35	18.88	13.22

Adocia Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Adocia Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Adocia's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Adocia (Adocia) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adocia (OTCPK:ADOIF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ADOC:France A89:Germany

Address

115 Avenue Lacassagne, Lyon, FRA, 69003

Website

https://www.adocia.com

Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.